Search

everythinglearnresearchcommunity

for

Search:↓

PF-998425 is a new, effective, and non-phototoxic treatment for skin conditions related to androgens.

More extensive trials are needed to understand tofacitinib's role in treating severe hair loss.

Tofacitinib effectively treated severe hair loss in a patient who didn't respond to other treatments.

Tofacitinib is somewhat effective for alopecia areata, but more research is needed on its safety and long-term effects.

Baricitinib helps with early hair regrowth in people with alopecia areata.

The new skin cream with FOL-005 safely promotes hair growth and is stable and user-friendly.

An 8-year-old girl with vitiligo developed extra hair growth on her knee after using tacrolimus ointment.

Finasteride complexes with HPβCD and polymers improve solubility, potentially enhancing hair loss treatment.

Trichoscopy helped diagnose and cure a child's hair loss caused by a fungal infection.

Oral and topical tofacitinib can help regrow hair in people with severe alopecia areata.

Fungal infections like ringworm affect skin, hair, and nails in humans and animals, requiring culture for diagnosis and specific treatments.

Baricitinib may effectively treat lichen planopilaris.

Stopping sunscreen use on the forehead led to hair regrowth in a woman with frontal fibrosing alopecia.

Oral tofacitinib can significantly improve recalcitrant lichen planopilaris.

The treatment helped reduce symptoms and stabilize the hairline in most patients with Frontal Fibrosing Alopecia, but hair regrowth was limited.

Tiny particles improved delivery of hair loss treatments to hair follicles, with lipid-based particles performing best.

Tofacitinib works well for treating alopecia areata, especially when combined with corticosteroids, but is less effective if the disease has lasted over 2 years.

Tofacitinib is a promising and safe treatment for moderate to severe alopecia areata.

Topical finasteride promotes hair growth with minimal side effects but needs more research for women and optimal use.

Once-daily 5% minoxidil foam and twice-daily 2% minoxidil solution are similarly effective and safe for female pattern hair loss.

Topical finasteride and flutamide reduce gland size and enzyme activity, with flutamide being more potent, potentially treating acne, seborrhea, hirsutism, and androgenic alopecia.

Oral Minoxidil could be a safe and effective alternative treatment for various non-androgenic alopecias.

Methotrexate may help stabilize frontal fibrosing alopecia.

Flutamide effectively reduced excessive hair growth and improved related symptoms in hirsutism patients without significant side effects.

FOL-005 peptide may help treat excessive hair growth safely.

Minocycline may cause hair loss by increasing DHT levels, but finasteride can help counteract this effect.

Early diagnosis and treatment of favus can prevent permanent hair loss.

The EFH-SLM cream is more effective and gentler for treating excessive hair growth in women.

Oral cyclosporine is more effective and safer than betamethasone for treating alopecia areata.